• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Enlivex Therapeutics(ENLV.US)

Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov26
Enlivex Therapeutics Ltd. Completes $212 Million Private Placement to Advance Clinical Development
13:03
Nov15
Enlivex Therapeutics released FY2025 9 Months Earnings on November 14 (EST), with actual revenue of USD 0 and EPS of USD -0.3216
04:00
Enlivex Therapeutics released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.0917 (forecast USD -0.12)
04:00
Aug30
Enlivex Therapeutics released FY2025 Semi-Annual earnings on August 29 (EST), actual revenue USD 0, actual EPS USD -0.2234
03:00
Enlivex Therapeutics released FY2025 Q2 earnings on August 29 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.0799 (forecast USD -0.16)
03:00
Jun10
Enlivex Therapeutics to Present Knee Osteoarthritis Cell Therapy Data at EULAR Conference
12:33

Schedules & Filings

Schedules
Filings
Nov14
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -2.205 M, EPS -0.0917

Aug29
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -1.868 M, EPS -0.0799

May30
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -3.452 M, EPS -0.1499

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
INBS
11.710
+185.61%
+7.628
ANGH
3.878
+67.16%
+1.542
ESHA
22.220
+54.52%
+7.840
NCL
0.2874
+48.14%
+0.094
ESHAR
0.2500
+47.06%
+0.080
SIDU
3.535
+32.40%
+0.870
RDACR
0.2493
+31.21%
+0.059
ULY
3.580
+29.70%
+0.820
ORIS
1.565
+28.28%
+0.340
VNDA
8.950
+27.31%
+1.920
View More